biomarker conference - events.marketsandmarkets.comevents.marketsandmarkets.com/eventpdf/2017...

2nd Annual

Biomarker ConferenceDriving precision medicine: CDx, Immuno-Oncology, Translational Sciences &Novel Technologies

6 - 7 February 2017 San Diego Marriott La Jolla, San Diego

Postshow Report 2017Postshow Report 2017

2nd Annual

Biomarker ConferenceDriving precision medicine: CDx, Immuno-Oncology, Translational Sciences &Novel Technologies6 - 7 February 2017 San Diego Marriott La Jolla, San Diego

events.marketsandmarkets.com

MARKETSANDMARKETS

2nd Annual



The 2nd Annual Biomarker Conference took place on the 6th and 7th of Feb 2017 at La Jolla, San Diego in California, USA. It was co-located with other two events 2nd Annual Genome Engineering and Editing and NGS data analysis and Informatics Congress.

The event hosted more than 320 attendees and received an overwhelming response on all the three programs. Sponsors and exhibitors shared a very positive feedback as they loved the ample networking opportunities and one on one discussions with the attendees.

We now look forward to put-up another successful show and hope can have everything for everyone working in this field.

The 3rd Annual Biomarker Conference, Feb 2018, SD, USA registrations shall open by August 2017.

This post-show report summarises the 2017 event to demonstrate how the conference has grown and plans to deliver and expand the event for the future. If you are already involved with us as an exhibitor, visitor or delegate, we would like to thank you for your continued support in making it such a great success.

Synopsis:

Key highlights at the conference:

Gary Kelloff, Special Advisor from NIH/NCI opened the conference and addressed the Keynote - Progress in development of circulating biomarkers, the promise of liquid biopsies

Mark Curran, VP Immunology Biomarkers from Janssen, Pharmaceutical Companies of Johnson and Johnson delivered an interesting talk on Challenges of drug and diagnostic co-development: Examples in auto-immune disorders

A very hot topic Companion diagnostics - Are we delivering on the promise? Was presented by Abdel Halim, VP Translational Medicine, Biomarkers & Diagnostics, Celldex Therapeutics

A panel discussion on Complementary Diagnostics v/s Companion Diagnostics - How do we ensure success in biomarker efforts? Saw lot of stimulating discussions and audience interactions with panellists like Abdel Halim, Mark Curran and Kamala K Maddali, VP, Biopharm Market Development, Collaborations and Companion Diagnostics from Cancer Genetics, Inc

Ann Kapoun, VP Translational Medicine from OncoMed Pharmaceuticals presented on Patient selection biomarkers in oncology

2nd Annual



Partners 2017

2nd Annual



Expert Speaker Panel

Jianda YuanDirector Translational Immuno-Oncology Research,Early Clinical Oncology, Merck, New York

Rajiv RajaDirector R & D Translational Medicine & Pharmacogenomics, MedImmune Astrazeneca, Maryland

Darrell BorgerDirector, Biomarker LaboratoryMass General Hospital, Massachusetts

Thomas SchlangeSenior Biomarker Scientist, Global Biomarker Research, Bayer Healthcare, UK

Dave HoonDirector, Molecular Oncology,John Wayne Cancer Institute, California

Gary KelloffSpecial AdvisorNIH/NCI, Washington D.C

Mark E. CurranVP Systems Pharmacology and Biomarkers, Immunology Therapeutic Area, Janssen Research & Development, LLC, Pennsylvania

Abdel HalimVP Translational Medicine, Biomarkers & DiagnosticsCelldex Therapeutics, New Jersey

Catherine TribouleySenior Director, Correlative Sciences Novartis, New York

Carl BarrettVP Translational ScienceAstrazeneca, Massachusetts

Sriram SathyanarayananDirector Translational SciencesJounce Therapeutics, Inc., Massachusetts

Razelle KurzrockChief, Division of Hematology and OncologyUCSD School of Medicine, California

Kamala K Maddali,VP, Biopharm Market Development, Collaborations and Companion DiagnosticsCancer Genetics, Inc., New Jersey

Janusz DutkowskiCEOData4Cure, Inc., California

Alexandre AkoulitchevCSOOxford BioDynamics Plc, United Kingdom

Aung NaingAsso. Prof. Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Texas

Janku FilipAssistant ProfessorThe University of Texas MD Anderson Cancer Center, Texas

Anneli AnderssonScientific Project ManagerNEBION AG, Switzerland

Saurabh GuptaAssociate Director Translational Medicine GroupTakeda Oncology, Massachusetts

Deepak KhatryScience Associate Director, Statistical SciencesMedImmune, Washington D.C

Niki HeinzBusiness Development DirectorAsterand Bioscience,United States/United Kingdom

Jon Armstrong CSOCofactor Genomics, San Diego

TuDung NguyenMedical Director, CGI-WestCancer Genetics, Inc., California

Ann Kapoun,VP Translational Medicine,Onco Med Pharmaceuticals

2nd Annual



Expert Speaker Panel

Matthew A. SpearChief Medical OfficerPoseida Therapeutics, California

Bob TerbrueggenFounder & CEODxTerity Diagnostics, California

Jeffrey MinerExecutive DirectorAstraZeneca (Ardea Biosciences), California

Matt JohnsonChief Technology OfficerAvacta Life Sciences, United Kingdom

Rob FannonVP, Biopharm SolutionsCancer Genetics Inc. North Carolina

Sandip P. PatelMedical Oncologist, Assistant Professor of Medicine, UC San Diego Health, San Diego

2nd Annual



Attendee Breakdown

Job Title Wise

Scientists, Researchers, Professors, Investigators

45%VPs, Sr. Directors, Heads, Managers

55%

Industry Wise

UK/Europe 5%

West USA 60%

East USA 35%

2nd Annual



Attendee 2017

•Abbott Laboratories•Agenovir Corp.•Aglient•Allergan•Ambrx•Applied StemCell, Inc.•Ardea Biosciences•Asterand Bioscience•Astrazeneca•AstraZeneca Pharmaceuticals•Avacta Life Sciences•Avere Systems•Benchling•Biogen•Biognosys•Bluebird Bio•Boehringer Ingelheim•Bristol-Myers Squibb•Cancer Genetics, Inc. (CGI)•Cedars-Sinai Medical Center•Celgene Corp.•Celldex Therapeutics•Cibus US•Cofactor Genomics•Columbia University•Cureline, Inc•Cyagen Biosciences•Dart Neuroscience•Dartmouth Medical School•Data4Cure Inc•Decibio Consulting•Dendreon•Desktop Genetics Ltd.•DiaCarta, Inc.•DNAnexus•DuPont•DxTerity•Editas Medicine•Effector Therapeutics•EMD Serono•Exeligen Scientific Inc•Ferring Pharmaceuticals•Ferring Research Institute•Galaxy Bio Inc•GE Healthcare•Genomics Institute of Novartis•Genoptix•Genoptix, a Novartis Company•George Washington University•Gilead Sciences Inc

•GlaxoSmithKline•GSK•Harvard Medical School•Hiroshima University, Japan•Hitachi-hta•Human Longevity Inc.•Huya Bioscience•HUYA Bioscience Int’l•Ibis Biosciences•Illumina•Innovative Genomics Initiative•Institute for Systems Biology•Intecept•Integrated DNA Technologies•I ntertek Pharmaceutical Services•J. Craig Venter Institute (JCVI)• Janssen Research & Development•John Wayne Cancer Institute•Johnson & Johnson Company•Jounce Therapeutics Inc.•JSC BIOCAD• Kaiser Permanente Research

Bank•Keck Graduate Institute•Kumamoto University•Kura Oncology• KWS Gateway Research Center•Locana, Inc.•Masaryk University Brno•Mayo Clinic•MD Anderson•MedImmune/AstraZeneca•MilliporeSigma•MIT•MoBio Laboratories•Molecular Health•Mount Sinai Genetic Testing Lab•National Cancer Institute• National Institute of General

Medical Sciences• National Institute of Standards

and Technology•National University•Nebion AG•Nektar Therapeutics•New England Biolabs•New York Genome Center

•NHGRI/NIH•Northeastern University•Novagene•Novartis•NUS•Oklahoma State University•OncoMed• Oregon Health & Science

University•Oxford BioDynamics PlC•Oxford Genetics Ltd.•Pacific Biomarkers•Pfizer•Pfizer Inc.•PhaseRx•Pitzer College•Poseida•Poseida Therapeutics, Inc.•PreCyte•Principia Biopharma•PTC Therapeutics•Quest Diagnostics•Ra Pharma• Rady Children Institute for

Genomic Medicine•Regenerative Medicine Institute• Regeneron Pharmaceuticals, Inc•Regulus•Regulus Therapeutics•Roche•Rutgers New Jersey Medical School•Salk Institute• San Diego Biomedical Research

Institute•San Diego State University• San Diego Supercomputer

Center, UCSD•San Francisco State University•SciDoc Publishers Pvt Ltd•Scripps Research Institute•Skolkovo•Sophia Genetics SA•SPARK Postdoctoral Fellow•Stanford University•Sunovion Pharmaceuticals•Synthetic Genomics Inc•Synthomics, Inc.•Takeda•Takeda Pharmaceutical• Texas Tech University Health

Sciences Center• The Jackson Laboratory for

Genomic Medicine• The Scripps Research Institute La

Jolla• The University of Texas MD

Anderson Cancer Center•Tocagen Inc.•transOMIC technologies Inc.•Twist Bioscience•UC Berkeley•UC Riverside• UC San Diego Moores Cancer

Center•UCLA•UCLA Dept of Pathology•UCSD•UCSD Moores Cancer Center• UCSD Systems Biology Research

Group•Université Laval•University at Buffalo• University of California at

Berkeley• University of California at

Riverside•University of California, Berkley•University of California, Davis•University of California, Riverside•University of California, San Diego•University of Chicago•University of Colorado•University of Ilinois at Chicago•University of Minnesota•University of Nebraska• University of New Mexico

Cancer Center•University of Oregon• University of Southern California• University of Utah School of

Medicine•UST Corporation• Vaccine Research Institute of San

Diego•Vertex Pharmaceuticals•Vical•Vical Incorporated•Yotta Biomed

2nd Annual



“It was a good setting and a well-organized conference. The size was perfect for networking and open discussions during the sessions. Thank you!”

“The conference program featured a number of leaders in the field presenting innovative research in the area of cancer diagnostics demonstrating novel techniques and approaches”

“First rate experience all around. We especially appreciated the attention M and M paid to setting up the one to one meetings and then the efforts they made to ensure the meetings actually happened. Quality speakers and impactful attendees… we will be back next year!”

“The conference was superbly organized and well attended by participants from academe, bio-pharma industry (representing start-ups, smaller biotechs, and large pharma), as well as technology sponsors providing information on novel products and services in the area of “precision medicine”. The 2-day event, focusing on biomarkers/CDx, genome editing, and NGS informatics, enabled the approximately 300 attendees to network among one another during planned breaks in the 3 concurrent sessions. The conference format worked very well.”

-Anneli Andersson Scientific Project Manager, NEBION AG, Switzerland

-Sandip P. Patel Medical Oncologist, Assistant Professor of Medicine, UC San Diego Health, California

-Bob Terbrueggen Founder & CEO, DxTerity Diagnostics, California

“A focused and productive meeting with interactive discussions and panels”

-Bob Terbrueggen VP Translational Medicine, Onco Med Pharmaceuticals, California

-Deepak Khatry Science Associate Director, Statistical Sciences, MedImmune, Washington D.C

1

2

3

4

5

2nd Annual



2nd Annual



MarketsandMarkets Events is a wholly owned division of MarketsandMarkets, a global market research and intelligence company producing over 1200 premium market research reports every year across 12 different industry verticals. By bringing together expert speakers from across the world and leading technology and service providers, Events provide a senior level educational and networking platform where knowledge is shared and partnerships and collaborations can be formed.

With offices in Asia, Europe and USA MarketsandMarkets ensures a truly global attendance at every event where attendees, speakers, exhibitors and sponsors can exchange ideas in a relaxed and professional environment.

About MarketsandMarkets:

Submitting Paper Proposal:You can submit your paper proposal on any of the event topics, which will be available on the events website shortly.

Contact: Garima Shrivastava | Conference Producer

E: [email protected] | T: +91 8806 931 519

Participating As A Delegate:You can always contribute by sharing your knowledge with your peers and colleagues.


Exhibiting Or Sponsoring At The Event:

In 2016, the event will be expanding its exhibition area and will offer an opportunity for exhibiting and showcasing your latest technologies, services, and products. We offer tailor made packages to sponsor the event based on your marketing budget.Contact: Abhinay Roy | Senior Sponsorship Manager


Media Alliances

We actively collaborate with publications, online portals and not-for-profit associations. To know more write to us.E: [email protected] | T: +91 20 3010 8270

How To Participate In 2018?

3rd Annual Biomarker ConferenceFebruary 2018, San Diego-CA, USA

Meet us again at the

+91 20 30108 270 | +44 (0)1865-842-976 [email protected] | www.marketsandmarkets.com

MARKETSANDMARKETS

biomarker conference - events.marketsandmarkets.comevents.marketsandmarkets.com/eventpdf/2017...

Documents